Epigenica

📍 Stockholm, Sweden🗓 Founded 2020👥 12 employees💰 Last funded Nov 2023
Biotechnology🌐 epigenica.se
Website LinkedIn
Epigenica is a life sciences technology company at the forefront of innovations in epigenetic research. The company’s EpiFinder platform enables researchers to perform comprehensive epigenetic studies at unprecedented speed, scalability, and affordability. Epigenica is building a portfolio of products based on the EpiFinder platform to offer comprehensive high-throughput profiling at different depths of detail with an array of possible starting materials. The platform is powered by the company’s patented and proprietary high-throughput, multiplex, quantitative ChIP-seq technology (hmqChIP), the first commercial kit of its kind. With the advantages of the EpiFinder platform, Epigenica is helping researchers advance biomedical research, drug discovery and development, precision medicine, diagnostics, and therapeutics for aging and longevity.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Epigenica?
Epigenica has 1 investors on record on gritt.io, 1 mid-stage.
When did Epigenica last raise funding?
The most recent investment in Epigenica recorded on gritt.io was in November 2023.
When was Epigenica founded?
Epigenica was founded in 2020.
What industry is Epigenica in?
Epigenica operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Epigenica based?
Epigenica is headquartered in Stockholm, Sweden.